| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |